These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 39068317

  • 1. Interval Metastases After Neoadjuvant Chemoradiotherapy for Patients with Locally Advanced Esophageal Cancer: A Multicenter Observational Cohort Study.
    van der Zijden CJ, van der Sluis PC, Mostert B, Nuyttens JJME, van Lanschot JJB, Spaander MCW, Valkema R, Coene PPLO, Dekker JWT, Fiets WE, Hartgrink HH, Hazen WL, Kouwenhoven EA, Nieuwenhuijzen GAP, Rosman C, van Sandick JW, Sosef MN, van der Zaag ES, Lagarde SM, Wijnhoven BPL.
    Ann Surg Oncol; 2024 Nov; 31(12):7759-7766. PubMed ID: 39068317
    [Abstract] [Full Text] [Related]

  • 2. Detecting Interval Distant Metastases With 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer.
    Kroese TE, Ruurda JP, Bakker AS, Jairam J, Mook S, van der Horst S, Meijer GJ, Haj Mohammad N, van Rossum PSN, van Hillegersberg R.
    Clin Nucl Med; 2022 Jun 01; 47(6):496-502. PubMed ID: 35384907
    [Abstract] [Full Text] [Related]

  • 3. Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
    Xu X, Sun ZY, Wu HW, Zhang CP, Hu B, Rong L, Chen HY, Xie HY, Wang YM, Lin HP, Bai YR, Ye Q, Ma XM.
    Radiat Oncol; 2021 Jul 19; 16(1):132. PubMed ID: 34281566
    [Abstract] [Full Text] [Related]

  • 4. Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature review.
    Voncken FEM, Aleman BMP, van Dieren JM, Grootscholten C, Lalezari F, van Sandick JW, Steinberg JD, Vegt E.
    Strahlenther Onkol; 2018 Feb 19; 194(2):156-163. PubMed ID: 29051991
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer.
    Gabriel E, Alnaji R, Du W, Attwood K, Kukar M, Hochwald S.
    Ann Surg Oncol; 2017 Jun 19; 24(6):1739-1746. PubMed ID: 28058562
    [Abstract] [Full Text] [Related]

  • 6. Clinical Significance of 18F-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma.
    Hamai Y, Hihara J, Emi M, Ibuki Y, Murakami Y, Nishibuchi I, Nagata Y, Aoki Y, Furukawa T, Okada M.
    Ann Surg Oncol; 2019 Jun 19; 26(6):1869-1878. PubMed ID: 30675704
    [Abstract] [Full Text] [Related]

  • 7. Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Leng X, He W, Yang H, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Liu H, Yang H, Li T, Zhang X, Li Q, Wang G, Mao T, Guo X, Lin T, Liu M, Fu J, Han Y.
    Ann Surg; 2021 Dec 01; 274(6):e1022-e1029. PubMed ID: 31855875
    [Abstract] [Full Text] [Related]

  • 8. Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.
    de Heer EC, Hulshoff JB, Klerk D, Burgerhof JGM, de Groot DJA, Plukker JTM, Hospers GAP.
    Ann Surg Oncol; 2017 Jul 01; 24(7):1811-1820. PubMed ID: 28188501
    [Abstract] [Full Text] [Related]

  • 9. Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients.
    Dijksterhuis WPM, Hulshoff JB, van Dullemen HM, Kats-Ugurlu G, Burgerhof JGM, Korteweg T, Mul VEM, Hospers GAP, Plukker JTM.
    Acta Oncol; 2019 Nov 01; 58(11):1640-1647. PubMed ID: 31397195
    [Abstract] [Full Text] [Related]

  • 10. Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using 18F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study.
    Borggreve AS, Goense L, van Rossum PSN, Heethuis SE, van Hillegersberg R, Lagendijk JJW, Lam MGEH, van Lier ALHMW, Mook S, Ruurda JP, van Vulpen M, Voncken FEM, Aleman BMP, Bartels-Rutten A, Ma J, Fang P, Musall BC, Lin SH, Meijer GJ.
    Int J Radiat Oncol Biol Phys; 2020 Apr 01; 106(5):998-1009. PubMed ID: 31987972
    [Abstract] [Full Text] [Related]

  • 11. Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.
    Borggreve AS, Mook S, Verheij M, Mul VEM, Bergman JJ, Bartels-Rutten A, Ter Beek LC, Beets-Tan RGH, Bennink RJ, van Berge Henegouwen MI, Brosens LAA, Defize IL, van Dieren JM, Dijkstra H, van Hillegersberg R, Hulshof MC, van Laarhoven HWM, Lam MGEH, van Lier ALHMW, Muijs CT, Nagengast WB, Nederveen AJ, Noordzij W, Plukker JTM, van Rossum PSN, Ruurda JP, van Sandick JW, Weusten BLAM, Voncken FEM, Yakar D, Meijer GJ, PRIDE study group.
    BMC Cancer; 2018 Oct 20; 18(1):1006. PubMed ID: 30342494
    [Abstract] [Full Text] [Related]

  • 12. Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
    Sasaki K, Uchikado Y, Okumura H, Omoto I, Kita Y, Arigami T, Uenosono Y, Owaki T, Maemura K, Natsugoe S.
    Anticancer Res; 2017 Feb 20; 37(2):859-864. PubMed ID: 28179343
    [Abstract] [Full Text] [Related]

  • 13. Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial.
    Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Han Y, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Yang H, Li T, Zhang X, Li Q, Wang G, Chen B, Mao T, Kong M, Guo X, Lin T, Liu M, Fu J.
    JAMA Surg; 2021 Aug 01; 156(8):721-729. PubMed ID: 34160577
    [Abstract] [Full Text] [Related]

  • 14. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
    Wang H, Tang H, Fang Y, Tan L, Yin J, Shen Y, Zeng Z, Zhu J, Hou Y, Du M, Jiao J, Jiang H, Gong L, Li Z, Liu J, Xie D, Li W, Lian C, Zhao Q, Chen C, Zheng B, Liao Y, Li K, Li H, Wu H, Dai L, Chen KN.
    JAMA Surg; 2021 May 01; 156(5):444-451. PubMed ID: 33729467
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
    Visser E, van Rossum PSN, Ruurda JP, van Hillegersberg R.
    Ann Surg; 2017 Nov 01; 266(5):863-869. PubMed ID: 28742691
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
    Kroese TE, Goense L, van Hillegersberg R, de Keizer B, Mook S, Ruurda JP, van Rossum PSN.
    Dis Esophagus; 2018 Dec 01; 31(12):. PubMed ID: 29917073
    [Abstract] [Full Text] [Related]

  • 20. Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Jeong Y, Kim JH, Kim SB, Yoon DH, Park SI, Kim YH, Kim HR, Jung HY, Lee GH, Ryu JS.
    J Surg Oncol; 2014 Apr 01; 109(5):472-7. PubMed ID: 24301552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.